Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Anisodamine Market Research Report 2025

Global Anisodamine Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-01

Pages: 96 Pages

Report ld: 3448962

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Anisodamine was valued at US$ 84.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Anisodamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anisodamine.

The Anisodamine market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anisodamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anisodamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Merck

ALB Technology Limited

Northeast Pharmaceutical Group

Dayang chem (Hangzhou)

Wuhan WUJING MEDICINE

Hangzhou Minsheng Pharmaceutical

HENAN PURUI MEDICINE

BRILLIANT PHARMACEUTICALS

Qingdao Huanghai Pharmaceutical

Nanjing Tianlang Pharmaceutical

Henan Kangqian Medical Technology

Shanghai yuanye Bio-Technology

Wsembio

Segment by Type

Injection

Tablet

Drops

Segment by Application

Visceral

Brain

Eyes

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Anisodamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Anisodamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Anisodamine Market Overview

1.1 Product Definition

1.2 Anisodamine by Type

1.2.1 Global Anisodamine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injection

1.2.3 Tablet

1.2.4 Drops

1.3 Anisodamine by Application

1.3.1 Global Anisodamine Market Value by Application (2024 VS 2031)

1.3.2 Visceral

1.3.3 Brain

1.3.4 Eyes

1.3.5 Others

1.4 Global Anisodamine Market Size Estimates and Forecasts

1.4.1 Global Anisodamine Revenue 2020-2031

1.4.2 Global Anisodamine Sales 2020-2031

1.4.3 Global Anisodamine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Anisodamine Market Competition by Manufacturers

2.1 Global Anisodamine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Anisodamine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Anisodamine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Anisodamine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anisodamine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anisodamine, Product Type & Application

2.7 Global Key Manufacturers of Anisodamine, Date of Enter into This Industry

2.8 Global Anisodamine Market Competitive Situation and Trends

2.8.1 Global Anisodamine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anisodamine Players Market Share by Revenue

2.8.3 Global Anisodamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anisodamine Market Scenario by Region

3.1 Global Anisodamine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Anisodamine Sales by Region: 2020-2031

3.2.1 Global Anisodamine Sales by Region: 2020-2025

3.2.2 Global Anisodamine Sales by Region: 2026-2031

3.3 Global Anisodamine Revenue by Region: 2020-2031

3.3.1 Global Anisodamine Revenue by Region: 2020-2025

3.3.2 Global Anisodamine Revenue by Region: 2026-2031

3.4 North America Anisodamine Market Facts & Figures by Country

3.4.1 North America Anisodamine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Anisodamine Sales by Country (2020-2031)

3.4.3 North America Anisodamine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Anisodamine Market Facts & Figures by Country

3.5.1 Europe Anisodamine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Anisodamine Sales by Country (2020-2031)

3.5.3 Europe Anisodamine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anisodamine Market Facts & Figures by Region

3.6.1 Asia Pacific Anisodamine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Anisodamine Sales by Region (2020-2031)

3.6.3 Asia Pacific Anisodamine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Anisodamine Market Facts & Figures by Country

3.7.1 Latin America Anisodamine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Anisodamine Sales by Country (2020-2031)

3.7.3 Latin America Anisodamine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Anisodamine Market Facts & Figures by Country

3.8.1 Middle East and Africa Anisodamine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Anisodamine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Anisodamine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Anisodamine Sales by Type (2020-2031)

4.1.1 Global Anisodamine Sales by Type (2020-2025)

4.1.2 Global Anisodamine Sales by Type (2026-2031)

4.1.3 Global Anisodamine Sales Market Share by Type (2020-2031)

4.2 Global Anisodamine Revenue by Type (2020-2031)

4.2.1 Global Anisodamine Revenue by Type (2020-2025)

4.2.2 Global Anisodamine Revenue by Type (2026-2031)

4.2.3 Global Anisodamine Revenue Market Share by Type (2020-2031)

4.3 Global Anisodamine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Anisodamine Sales by Application (2020-2031)

5.1.1 Global Anisodamine Sales by Application (2020-2025)

5.1.2 Global Anisodamine Sales by Application (2026-2031)

5.1.3 Global Anisodamine Sales Market Share by Application (2020-2031)

5.2 Global Anisodamine Revenue by Application (2020-2031)

5.2.1 Global Anisodamine Revenue by Application (2020-2025)

5.2.2 Global Anisodamine Revenue by Application (2026-2031)

5.2.3 Global Anisodamine Revenue Market Share by Application (2020-2031)

5.3 Global Anisodamine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Anisodamine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 ALB Technology Limited

6.2.1 ALB Technology Limited Company Information

6.2.2 ALB Technology Limited Description and Business Overview

6.2.3 ALB Technology Limited Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 ALB Technology Limited Anisodamine Product Portfolio

6.2.5 ALB Technology Limited Recent Developments/Updates

6.3 Northeast Pharmaceutical Group

6.3.1 Northeast Pharmaceutical Group Company Information

6.3.2 Northeast Pharmaceutical Group Description and Business Overview

6.3.3 Northeast Pharmaceutical Group Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Northeast Pharmaceutical Group Anisodamine Product Portfolio

6.3.5 Northeast Pharmaceutical Group Recent Developments/Updates

6.4 Dayang chem (Hangzhou)

6.4.1 Dayang chem (Hangzhou) Company Information

6.4.2 Dayang chem (Hangzhou) Description and Business Overview

6.4.3 Dayang chem (Hangzhou) Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Dayang chem (Hangzhou) Anisodamine Product Portfolio

6.4.5 Dayang chem (Hangzhou) Recent Developments/Updates

6.5 Wuhan WUJING MEDICINE

6.5.1 Wuhan WUJING MEDICINE Company Information

6.5.2 Wuhan WUJING MEDICINE Description and Business Overview

6.5.3 Wuhan WUJING MEDICINE Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Wuhan WUJING MEDICINE Anisodamine Product Portfolio

6.5.5 Wuhan WUJING MEDICINE Recent Developments/Updates

6.6 Hangzhou Minsheng Pharmaceutical

6.6.1 Hangzhou Minsheng Pharmaceutical Company Information

6.6.2 Hangzhou Minsheng Pharmaceutical Description and Business Overview

6.6.3 Hangzhou Minsheng Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hangzhou Minsheng Pharmaceutical Anisodamine Product Portfolio

6.6.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates

6.7 HENAN PURUI MEDICINE

6.7.1 HENAN PURUI MEDICINE Company Information

6.7.2 HENAN PURUI MEDICINE Description and Business Overview

6.7.3 HENAN PURUI MEDICINE Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 HENAN PURUI MEDICINE Anisodamine Product Portfolio

6.7.5 HENAN PURUI MEDICINE Recent Developments/Updates

6.8 BRILLIANT PHARMACEUTICALS

6.8.1 BRILLIANT PHARMACEUTICALS Company Information

6.8.2 BRILLIANT PHARMACEUTICALS Description and Business Overview

6.8.3 BRILLIANT PHARMACEUTICALS Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 BRILLIANT PHARMACEUTICALS Anisodamine Product Portfolio

6.8.5 BRILLIANT PHARMACEUTICALS Recent Developments/Updates

6.9 Qingdao Huanghai Pharmaceutical

6.9.1 Qingdao Huanghai Pharmaceutical Company Information

6.9.2 Qingdao Huanghai Pharmaceutical Description and Business Overview

6.9.3 Qingdao Huanghai Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Qingdao Huanghai Pharmaceutical Anisodamine Product Portfolio

6.9.5 Qingdao Huanghai Pharmaceutical Recent Developments/Updates

6.10 Nanjing Tianlang Pharmaceutical

6.10.1 Nanjing Tianlang Pharmaceutical Company Information

6.10.2 Nanjing Tianlang Pharmaceutical Description and Business Overview

6.10.3 Nanjing Tianlang Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nanjing Tianlang Pharmaceutical Anisodamine Product Portfolio

6.10.5 Nanjing Tianlang Pharmaceutical Recent Developments/Updates

6.11 Henan Kangqian Medical Technology

6.11.1 Henan Kangqian Medical Technology Company Information

6.11.2 Henan Kangqian Medical Technology Description and Business Overview

6.11.3 Henan Kangqian Medical Technology Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Henan Kangqian Medical Technology Anisodamine Product Portfolio

6.11.5 Henan Kangqian Medical Technology Recent Developments/Updates

6.12 Shanghai yuanye Bio-Technology

6.12.1 Shanghai yuanye Bio-Technology Company Information

6.12.2 Shanghai yuanye Bio-Technology Description and Business Overview

6.12.3 Shanghai yuanye Bio-Technology Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shanghai yuanye Bio-Technology Anisodamine Product Portfolio

6.12.5 Shanghai yuanye Bio-Technology Recent Developments/Updates

6.13 Wsembio

6.13.1 Wsembio Company Information

6.13.2 Wsembio Description and Business Overview

6.13.3 Wsembio Anisodamine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Wsembio Anisodamine Product Portfolio

6.13.5 Wsembio Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anisodamine Industry Chain Analysis

7.2 Anisodamine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anisodamine Production Mode & Process Analysis

7.4 Anisodamine Sales and Marketing

7.4.1 Anisodamine Sales Channels

7.4.2 Anisodamine Distributors

7.5 Anisodamine Customer Analysis

8 Anisodamine Market Dynamics

8.1 Anisodamine Industry Trends

8.2 Anisodamine Market Drivers

8.3 Anisodamine Market Challenges

8.4 Anisodamine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Anisodamine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Anisodamine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Anisodamine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Anisodamine Sales (Ton) of Key Manufacturers (2020-2025)

Table 5. Global Anisodamine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Anisodamine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Anisodamine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Anisodamine Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Anisodamine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anisodamine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anisodamine, Product Type & Application

Table 12. Global Key Manufacturers of Anisodamine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anisodamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anisodamine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anisodamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Anisodamine Sales by Region (2020-2025) & (Ton)

Table 18. Global Anisodamine Sales Market Share by Region (2020-2025)

Table 19. Global Anisodamine Sales by Region (2026-2031) & (Ton)

Table 20. Global Anisodamine Sales Market Share by Region (2026-2031)

Table 21. Global Anisodamine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Anisodamine Revenue Market Share by Region (2020-2025)

Table 23. Global Anisodamine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Anisodamine Revenue Market Share by Region (2026-2031)

Table 25. North America Anisodamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Anisodamine Sales by Country (2020-2025) & (Ton)

Table 27. North America Anisodamine Sales by Country (2026-2031) & (Ton)

Table 28. North America Anisodamine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Anisodamine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Anisodamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Anisodamine Sales by Country (2020-2025) & (Ton)

Table 32. Europe Anisodamine Sales by Country (2026-2031) & (Ton)

Table 33. Europe Anisodamine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Anisodamine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Anisodamine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Anisodamine Sales by Region (2020-2025) & (Ton)

Table 37. Asia Pacific Anisodamine Sales by Region (2026-2031) & (Ton)

Table 38. Asia Pacific Anisodamine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Anisodamine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Anisodamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Anisodamine Sales by Country (2020-2025) & (Ton)

Table 42. Latin America Anisodamine Sales by Country (2026-2031) & (Ton)

Table 43. Latin America Anisodamine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Anisodamine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Anisodamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Anisodamine Sales by Country (2020-2025) & (Ton)

Table 47. Middle East and Africa Anisodamine Sales by Country (2026-2031) & (Ton)

Table 48. Middle East and Africa Anisodamine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Anisodamine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Anisodamine Sales (Ton) by Type (2020-2025)

Table 51. Global Anisodamine Sales (Ton) by Type (2026-2031)

Table 52. Global Anisodamine Sales Market Share by Type (2020-2025)

Table 53. Global Anisodamine Sales Market Share by Type (2026-2031)

Table 54. Global Anisodamine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Anisodamine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Anisodamine Revenue Market Share by Type (2020-2025)

Table 57. Global Anisodamine Revenue Market Share by Type (2026-2031)

Table 58. Global Anisodamine Price (US$/Ton) by Type (2020-2025)

Table 59. Global Anisodamine Price (US$/Ton) by Type (2026-2031)

Table 60. Global Anisodamine Sales (Ton) by Application (2020-2025)

Table 61. Global Anisodamine Sales (Ton) by Application (2026-2031)

Table 62. Global Anisodamine Sales Market Share by Application (2020-2025)

Table 63. Global Anisodamine Sales Market Share by Application (2026-2031)

Table 64. Global Anisodamine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Anisodamine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Anisodamine Revenue Market Share by Application (2020-2025)

Table 67. Global Anisodamine Revenue Market Share by Application (2026-2031)

Table 68. Global Anisodamine Price (US$/Ton) by Application (2020-2025)

Table 69. Global Anisodamine Price (US$/Ton) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Merck Anisodamine Product

Table 74. Merck Recent Developments/Updates

Table 75. ALB Technology Limited Company Information

Table 76. ALB Technology Limited Description and Business Overview

Table 77. ALB Technology Limited Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. ALB Technology Limited Anisodamine Product

Table 79. ALB Technology Limited Recent Developments/Updates

Table 80. Northeast Pharmaceutical Group Company Information

Table 81. Northeast Pharmaceutical Group Description and Business Overview

Table 82. Northeast Pharmaceutical Group Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Northeast Pharmaceutical Group Anisodamine Product

Table 84. Northeast Pharmaceutical Group Recent Developments/Updates

Table 85. Dayang chem (Hangzhou) Company Information

Table 86. Dayang chem (Hangzhou) Description and Business Overview

Table 87. Dayang chem (Hangzhou) Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Dayang chem (Hangzhou) Anisodamine Product

Table 89. Dayang chem (Hangzhou) Recent Developments/Updates

Table 90. Wuhan WUJING MEDICINE Company Information

Table 91. Wuhan WUJING MEDICINE Description and Business Overview

Table 92. Wuhan WUJING MEDICINE Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Wuhan WUJING MEDICINE Anisodamine Product

Table 94. Wuhan WUJING MEDICINE Recent Developments/Updates

Table 95. Hangzhou Minsheng Pharmaceutical Company Information

Table 96. Hangzhou Minsheng Pharmaceutical Description and Business Overview

Table 97. Hangzhou Minsheng Pharmaceutical Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Hangzhou Minsheng Pharmaceutical Anisodamine Product

Table 99. Hangzhou Minsheng Pharmaceutical Recent Developments/Updates

Table 100. HENAN PURUI MEDICINE Company Information

Table 101. HENAN PURUI MEDICINE Description and Business Overview

Table 102. HENAN PURUI MEDICINE Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. HENAN PURUI MEDICINE Anisodamine Product

Table 104. HENAN PURUI MEDICINE Recent Developments/Updates

Table 105. BRILLIANT PHARMACEUTICALS Company Information

Table 106. BRILLIANT PHARMACEUTICALS Description and Business Overview

Table 107. BRILLIANT PHARMACEUTICALS Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. BRILLIANT PHARMACEUTICALS Anisodamine Product

Table 109. BRILLIANT PHARMACEUTICALS Recent Developments/Updates

Table 110. Qingdao Huanghai Pharmaceutical Company Information

Table 111. Qingdao Huanghai Pharmaceutical Description and Business Overview

Table 112. Qingdao Huanghai Pharmaceutical Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Qingdao Huanghai Pharmaceutical Anisodamine Product

Table 114. Qingdao Huanghai Pharmaceutical Recent Developments/Updates

Table 115. Nanjing Tianlang Pharmaceutical Company Information

Table 116. Nanjing Tianlang Pharmaceutical Description and Business Overview

Table 117. Nanjing Tianlang Pharmaceutical Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Nanjing Tianlang Pharmaceutical Anisodamine Product

Table 119. Nanjing Tianlang Pharmaceutical Recent Developments/Updates

Table 120. Henan Kangqian Medical Technology Company Information

Table 121. Henan Kangqian Medical Technology Description and Business Overview

Table 122. Henan Kangqian Medical Technology Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Henan Kangqian Medical Technology Anisodamine Product

Table 124. Henan Kangqian Medical Technology Recent Developments/Updates

Table 125. Shanghai yuanye Bio-Technology Company Information

Table 126. Shanghai yuanye Bio-Technology Description and Business Overview

Table 127. Shanghai yuanye Bio-Technology Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Shanghai yuanye Bio-Technology Anisodamine Product

Table 129. Shanghai yuanye Bio-Technology Recent Developments/Updates

Table 130. Wsembio Company Information

Table 131. Wsembio Description and Business Overview

Table 132. Wsembio Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Wsembio Anisodamine Product

Table 134. Wsembio Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Anisodamine Distributors List

Table 138. Anisodamine Customers List

Table 139. Anisodamine Market Trends

Table 140. Anisodamine Market Drivers

Table 141. Anisodamine Market Challenges

Table 142. Anisodamine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anisodamine

Figure 2. Global Anisodamine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Anisodamine Market Share by Type: 2024 & 2031

Figure 4. Injection Product Picture

Figure 5. Tablet Product Picture

Figure 6. Drops Product Picture

Figure 7. Global Anisodamine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Anisodamine Market Share by Application: 2024 & 2031

Figure 9. Visceral

Figure 10. Brain

Figure 11. Eyes

Figure 12. Others

Figure 13. Global Anisodamine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Anisodamine Market Size (2020-2031) & (US$ Million)

Figure 15. Global Anisodamine Sales (2020-2031) & (Ton)

Figure 16. Global Anisodamine Average Price (US$/Ton) & (2020-2031)

Figure 17. Anisodamine Report Years Considered

Figure 18. Anisodamine Sales Share by Manufacturers in 2024

Figure 19. Global Anisodamine Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Anisodamine Players: Market Share by Revenue in Anisodamine in 2024

Figure 21. Anisodamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Anisodamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Anisodamine Sales Market Share by Country (2020-2031)

Figure 24. North America Anisodamine Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Anisodamine Sales Market Share by Country (2020-2031)

Figure 28. Europe Anisodamine Revenue Market Share by Country (2020-2031)

Figure 29. Germany Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Anisodamine Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Anisodamine Revenue Market Share by Region (2020-2031)

Figure 36. China Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Anisodamine Sales Market Share by Country (2020-2031)

Figure 47. Latin America Anisodamine Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Anisodamine Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Anisodamine Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Anisodamine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Anisodamine by Type (2020-2031)

Figure 57. Global Revenue Market Share of Anisodamine by Type (2020-2031)

Figure 58. Global Anisodamine Price (US$/Ton) by Type (2020-2031)

Figure 59. Global Sales Market Share of Anisodamine by Application (2020-2031)

Figure 60. Global Revenue Market Share of Anisodamine by Application (2020-2031)

Figure 61. Global Anisodamine Price (US$/Ton) by Application (2020-2031)

Figure 62. Anisodamine Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Anisodamine market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Anisodamine market is 3.7% 2025 to 2031.

Which region is expected to have the highest market share? shouQi

What was the global market size of Anisodamine in 2025? shouQi

Which companies rank high in the global Anisodamine market? shouQi

Related Reports

Global Anisodamine Market Research Report 2024
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Published Date: 2024-01-21
Pages: 87
USD 2900.00
(Single User License)
Anisodamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Published Date: 2024-01-11
Pages: 120
USD 3950.00
(Single User License)

Global Anisodamine Market Research Report 2024
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Published: 2024-01-21
Pages: 87
USD 2900.00 (Single User License)
Anisodamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Published: 2024-01-11
Pages: 120
USD 3950.00 (Single User License)